Alcentra Capital Corp. (NASDAQ:ABDC) – Equities researchers at Zacks Investment Research decreased their Q3 2017 earnings estimates for Alcentra Capital Corp. in a research report issued to clients and investors on Monday. Zacks Investment Research analyst L. Thompson now expects that the asset manager will post earnings per share of $0.34 for the quarter, down from their previous estimate of $0.37. Zacks Investment Research also issued estimates for Alcentra Capital Corp.’s Q4 2017 earnings at $0.39 EPS, FY2017 earnings at $1.43 EPS and FY2018 earnings at $1.49 EPS.

TRADEMARK VIOLATION WARNING: This story was first reported by Daily Political and is owned by of Daily Political. If you are accessing this story on another publication, it was illegally stolen and reposted in violation of US & international trademark & copyright laws. The legal version of this story can be viewed at https://www.dailypolitical.com/2017/08/09/q3-2017-eps-estimates-for-alcentra-capital-corp-decreased-by-analyst-abdc.html.

Several other analysts have also weighed in on the stock. Keefe, Bruyette & Woods set a $13.00 price objective on shares of Alcentra Capital Corp. and gave the company a “hold” rating in a research note on Sunday. TheStreet lowered shares of Alcentra Capital Corp. from a “b” rating to a “c+” rating in a research note on Monday, July 24th. Raymond James Financial, Inc. lowered shares of Alcentra Capital Corp. from a “strong-buy” rating to an “outperform” rating and lowered their price objective for the company from $16.00 to $14.00 in a research note on Monday, July 17th. Finally, DA Davidson began coverage on shares of Alcentra Capital Corp. in a research report on Wednesday, July 5th. They issued a “buy” rating and a $15.00 price target for the company. Four investment analysts have rated the stock with a hold rating and two have given a buy rating to the company. The company presently has an average rating of “Hold” and an average price target of $13.50.

Shares of Alcentra Capital Corp. (NASDAQ ABDC) opened at 10.48 on Wednesday. Alcentra Capital Corp. has a 52 week low of $10.39 and a 52 week high of $14.73. The firm has a 50-day moving average of $12.85 and a 200 day moving average of $13.19.

The firm also recently declared a quarterly dividend, which will be paid on Thursday, October 5th. Investors of record on Saturday, September 30th will be given a $0.34 dividend. This represents a $1.36 annualized dividend and a yield of 12.98%. The ex-dividend date of this dividend is Thursday, September 28th. Alcentra Capital Corp.’s payout ratio is currently -1,700.00%.

In related news, major shareholder Of New York Mellon Corp Bank sold 1,691,839 shares of Alcentra Capital Corp. stock in a transaction on Monday, May 22nd. The shares were sold at an average price of $13.13, for a total value of $22,213,846.07. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Steven H. Reiff purchased 11,668 shares of Alcentra Capital Corp. stock in a transaction that occurred on Monday, August 7th. The stock was acquired at an average cost of $10.72 per share, with a total value of $125,080.96. Following the transaction, the director now owns 7,000 shares in the company, valued at approximately $75,040. The disclosure for this purchase can be found here. Company insiders own 4.96% of the company’s stock.

A number of hedge funds have recently bought and sold shares of the stock. Salzhauer Michael increased its stake in Alcentra Capital Corp. by 62.6% in the second quarter. Salzhauer Michael now owns 47,292 shares of the asset manager’s stock valued at $643,000 after buying an additional 18,200 shares during the last quarter. Bank of Montreal Can acquired a new stake in Alcentra Capital Corp. during the second quarter valued at about $163,000. Confluence Investment Management LLC increased its stake in Alcentra Capital Corp. by 2.7% in the second quarter. Confluence Investment Management LLC now owns 209,528 shares of the asset manager’s stock valued at $2,847,000 after buying an additional 5,566 shares during the last quarter. UBS Group AG increased its stake in Alcentra Capital Corp. by 20.7% in the first quarter. UBS Group AG now owns 258,940 shares of the asset manager’s stock valued at $3,558,000 after buying an additional 44,387 shares during the last quarter. Finally, Ares Management LLC increased its stake in Alcentra Capital Corp. by 3.5% in the first quarter. Ares Management LLC now owns 434,049 shares of the asset manager’s stock valued at $5,964,000 after buying an additional 14,525 shares during the last quarter. 43.52% of the stock is owned by institutional investors and hedge funds.

Alcentra Capital Corp. Company Profile

Alcentra Capital Corporation is a specialty finance company that operates as a non-diversified, closed-end management investment company. The Company operates as a business development company and a regulated investment company. It provides customized debt and equity financing solutions to lower middle-market companies, which are companies having annual earnings, before interest, taxes, depreciation and amortization of between $5 million and $15 million, and/or revenues of between $10 million and $100 million.

Earnings History and Estimates for Alcentra Capital Corp. (NASDAQ:ABDC)

Receive News & Ratings for Alcentra Capital Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alcentra Capital Corp. and related companies with MarketBeat.com's FREE daily email newsletter.